M. Kohler

发表

R. Bast, A. Berchuck, M. Kohler, 1992, Hematology/oncology clinics of North America.

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum‐sensitive ovarian cancer

A. Berchuck, A. Secord, L. Havrilesky, 2012, Cancer.

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

J. Marks, P. Humphrey, R. Bast, 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.

P. Humphrey, R. Bast, A. Berchuck, 1994, Gynecologic oncology.

Overexpression and mutation of p53 in endometrial carcinoma.

P. Humphrey, R. Bast, A. Berchuck, 1992, Cancer research.

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

R. Bast, A. Berchuck, J. Boyd, 1994, American journal of obstetrics and gynecology.

The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

R. Bast, A. Berchuck, J. Boyd, 1994 .

Mutations of the Ki-ras oncogene in endometrial carcinoma.

A. Berchuck, J. Boyd, J. McLachlan, 1992, American journal of obstetrics and gynecology.

Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma

M. Kohler, D. Clarke‐Pearson, J. Soper, 1991, Cancer.

Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing.

M. Kohler, S. Mathur, R. Mathur, 2005, Cancer biomarkers : section A of Disease markers.

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.

P. Humphrey, R. Bast, A. Berchuck, 1993, Obstetrics and gynecology.

Cell growth regulation in epithelial ovarian cancer

R. Bast, A. Berchuck, M. Kohler, 1993, Cancer.

Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.

R. Bast, A. Berchuck, M. Kohler, 1993, American journal of clinical pathology.

Distribution of integrin cell adhesion molecules in endometrial cancer.

A. Berchuck, M. Kohler, S. Albelda, 1995, The American journal of pathology.

Growth regulation and transformation of ovarian epithelium

R. Bast, A. Berchuck, R. Whitaker, 2010, Cancer.

Why do we continue to overtreat stage Ia carcinoma of the cervix?

M. Kohler, J. Pierce, W. Creasman, 2017, American journal of obstetrics and gynecology.

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

P. Boyle, M. Kohler, P. Maisonneuve, 2004, Gynecologic oncology.

How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?

M. Kohler, J. Korte, W. Creasman, 2009, American journal of obstetrics and gynecology.

Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?

M. Kohler, C. Watson, J. Pierce, 2015, Gynecologic oncology.

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.

P. Humphrey, R. Bast, A. Berchuck, 1993, American journal of obstetrics and gynecology.

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

A. Berchuck, H. Sasaki, H. Takahashi, 1993, Cancer research.

Ultrasound‐guided tandem placement for low‐dose‐rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation

M. Kohler, J. Watkins, S. Ackerman, 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Malignant Germ Cell Tumors of the Ovary

P. Disaia, M. Kohler, F. Cappuccini, 2000, Obstetrics and gynecology.

Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?

M. Kohler, W. Creasman, 2004, Gynecologic oncology.

Mutations of the E–cadherin gene in human gynecologic cancers

A. Berchuck, J. Boyd, M. Kohler, 1994, Nature Genetics.

Allelotype of endometrial carcinoma.

H. Sasaki, J. Barrett, H. Takahashi, 1994, Cancer research.

Genetic instability of microsatellites in endometrial carcinoma.

A. Berchuck, J. Boyd, J. Boyd, 1993, Cancer research.

Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatment.

K. Buetow, A. Berchuck, A. Godwin, 1996, Current problems in cancer.

Mutational Analysis of the Estrogen‐Receptor Gene in Endometrial Carcinoma

A. Berchuck, J. Boyd, A. Elbendary, 1995, Obstetrics and gynecology.

p53 overexpression in advanced-stage endometrial adenocarcinoma.

A. Berchuck, R. Dodge, P. Carney, 1996, American journal of obstetrics and gynecology.

Necrotizing Fasciitis and Toxic Shock Syndrome from Clostridium septicum following a Term Cesarean Delivery

M. Kohler, E. Eriksson, J. Pierce, 2014, Case reports in obstetrics and gynecology.

Multivariable analysis of DNA ploidy, p53, and HER‐2/neu as prognostic factors in endometrial cancer

R. Bast, A. Berchuck, R. Bentley, 1994, Cancer.

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

P. Humphrey, R. Bast, B. Ponder, 1992, Journal of the National Cancer Institute.

Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B

M. Kohler, W. Creasman, S. Mathur, 2005 .

M. Kohler, W. Creasman, S. Mathur, 2005, Gynecologic oncology.

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

R. Bast, A. Berchuck, I. Jacobs, 1993, Journal of the National Cancer Institute.

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

B. Monk, R. Burger, M. Kohler, 2000, Cancer.

Evaluation of Risk Factors for Infectious Morbidity in Postoperative Gynecologic Oncology Patients: A Time for a New Paradigm?

M. Kohler, J. Korte, W. Creasman, 2013 .

Adjuvant therapy in the treatment of stage II uterine carcinoma

M. Kohler, W. Creasman, L. Harbin, 2018, Gynecologic Oncology.

Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.

R. Bentley, M. Tsao, J. McLachlan, 1995, Cancer research.

D. Revicki, A. Secord, L. Havrilesky, 2011, Gynecologic oncology.

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.

M. Kohler, W. Creasman, S. Mathur, 2003, Gynecologic oncology.

Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium.

M. Kohler, W. Creasman, 2008, Future oncology.

Cost‐effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum‐sensitive, recurrent ovarian cancer

A. Berchuck, D. Revicki, A. Secord, 2012, Cancer.

Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer.

M. Kohler, W. Creasman, Heidi L. Sapp, 2008, American journal of obstetrics and gynecology.

The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma.

D. Sinha, M. Kohler, J. Watkins, 2008, European journal of obstetrics, gynecology, and reproductive biology.

A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report.

M. Kohler, W. Creasman, C. Billingsley, 2012, Journal of lower genital tract disease.